Sign in
CompletedNo phase

CT-guided vs Fluoroscopy-guided Trigeminal Ganglion Radiofrequency Thermocoagulation for Idiopathic Trigeminal Neuralgia

Key facts

Who runs it
Zagazig University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
68 people enrolled
Started
10 Nov 2024
Ended
10 Oct 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • CT-guided Radiofrequency Thermocoagulation (RFT)
  • Fluoroscopy-guided Radiofrequency Thermocoagulation (RFT)
Record updated
22 September 2026

Who can take part

Age
18 years to 60 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 16 criteriaShow less

Who can take part

  • Age >18 years
  • Idiopathic trigeminal neuralgia (TN) based on the International Headache Society criteria
  • Pain for at least six months and a NRS score greater than 6 despite medical treatment
  • Able to provide informed consent
  • Agree to follow the study procedures and attend follow-up visits

Who cannot take part

  • Previous interventional procedures or surgery for TN
  • Cardiac pacemaker
  • Renal-hepatic insufficiency
  • Diagnosis of psychiatric illness
  • Malignancy
  • Injection site or systemic infection
  • Vascular compression of the trigeminal nerve by MRI and MRI angiography and the presence of secondary causes such as multiple sclerosis
  • Trigeminal autonomic cephalalgias accompanied by autonomic symptoms
  • Dental or temporomandibular joint pathologies
  • Coagulopathy or use of antiaggregants and anticoagulants
  • Current participation in another clinical trial that could interfere with the outcomes of this study

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to compare the effectiveness and safety of CT-guided versus fluoroscopy-guided trigeminal ganglion radiofrequency thermocoagulation (TG-RFT) in treating idiopathic trigeminal neuralgia (TN) in adults aged 18 and older.

Read full original descriptionShow less

The main questions it aims to answer are:

* Does CT-guided TG-RFT provide better pain relief compared to fluoroscopy-guided TG-RFT? * What are the differences in medication consumption between the two methods? * What are the procedure-related adverse events for both methods?

Investigators will compare CT-guided TG-RFT to fluoroscopy-guided TG-RFT to see if one method is superior in treating idiopathic TN.

Participants will:

* Undergo either CT-guided or fluoroscopy-guided TG-RFT procedure * Be monitored post-procedure and followed up at 1, 3, and 6 months for pain relief, medication consumption, and adverse events.

The 2 groups in the trial

  • CT-guided RFTTreatment being tested

    Participants will undergo CT-guided trigeminal ganglion radiofrequency thermocoagulation (RFT) with real-time CT imaging for needle placement and monitoring.

    Treatment: CT-guided Radiofrequency Thermocoagulation (RFT)

  • Fluoroscopy-guided RFTExisting treatment, for comparison

    Participants will undergo fluoroscopy-guided trigeminal ganglion radiofrequency thermocoagulation (RFT) with fluoroscopic imaging for needle placement and monitoring.

    Treatment: Fluoroscopy-guided Radiofrequency Thermocoagulation (RFT)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
CT-guided vs Fluoroscopy-guided Trigeminal Ganglion Radiofrequency Thermocoagulation for Idiopathic Trigeminal Neuralgia: A Randomized Controlled Trial
Record updated
22 September 2026